Clinical Trial Update: Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated autologous bone marrow–derived mesenchymal stem cells for lumbar degenerative disc disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Degenerative Disc Disease

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Red de Terapia Celular | Conditions: Intervertebral Disc Disease | Phase 1, Phase 2 | Status: COMPLETED